New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers Will Be Presented at the 2025 ASCO GU Symposium.

Using the Decipher Bladder test to determine each tumor’s molecular subtype, researchers found that NMIBC patients with ...

Genetic testing and at-home screenings for colon, prostate and cervical cancer give workers and their families access to ...

"Swabs were taken from bite wounds on the white shark and sequenced for remnant genetic material from the shark's predator. We were able to confirm the presence of killer whale DNA in the primary ...

Coren, 55, said urology nurses had taken a biopsy before informing him they had found "some cancer" but that "no treatment would be necessary for the moment". "In the very week that it was announced ...

Within seconds, he concluded that he had a predisposition for schizophrenia, a sky-high IQ, and prostate cancer ... simulation” that meshes your genetic tests together and shows you what ...

In collaboration with the University of Washington and the Undiagnosed Diseases Network (UDN), the study applied PacBio’s state-of-the-art Revio™ sequencing system to integrate long-read genomic, ...

"This study highlights the power of highly accurate long-read multiomic sequencing in understanding the genetic mechanisms behind complex rare diseases," said Andrew B. Stergachis, MD, PhD ...